Randomised controlled trial
Randomized Trial of Remote Assessment of Patients After an Acute Coronary Syndrome
- Randomised controlled trial
Authors' conclusion
The TELE-ACS study has shown that a telemedicine-based approach for the management of patients following ACS was associated with a reduction in hospital readmission, ED visits, unplanned coronary revascularization, and patient-reported symptoms.
Study context
- Population
- Patients with ACS and ≥1 CV risk factor, randomised before discharge3.6% drop-out
- Participants
- 337 patients
- Comparison
- Telemedicine-based approach vs standard care
- Primary endpoint
- Time to first readmission
- Follow-up
- 6 months
Primary result
Readmission
Hazard ratio
0.24
95% CI 0.13–0.44
P < 0.001
Telemedicine vs Standard care
HR 0.24 (95% CI 0.13–0.44); P < 0.001
As reported in the abstract
Secondary outcomes
| Outcome | HR (95% CI) | |
|---|---|---|
| ED attendance | 0.59 (0.40–0.89) | |
| 0.512Hazard ratio (log scale) |
Unplanned coronary revascularization
Patient-reported symptoms · 6 months
Chest pain
Breathlessness
Dizziness
Original publication
Randomized Trial of Remote Assessment of Patients After an Acute Coronary Syndrome. J Am Coll Cardiol. Published 6 April 2024. doi:10.1016/j.jacc.2024.03.398
Summarised from the published abstract; every number is checked against it